BackSteminent Biotherapeutics Overview

Steminent Biotherapeutics Total Liabilities

Track Steminent Biotherapeutics's total liabilities ($92M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$92.28M

Peer trimmed avg / median

Loading

Steminent Biotherapeutics Total Liabilities History

Loading

Steminent Biotherapeutics vs. peers: Total Liabilities Comparison

Loading

Steminent Biotherapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Steminent Biotherapeutics (7729.TWO) FAQ

Steminent Biotherapeutics (7729.TWO) currently reports a total liabilities of $92M as of September 2026. Use the charts on this page to explore Steminent Biotherapeutics's total liabilities history and peer comparisons.

Steminent Biotherapeutics reported $92M in total liabilities as of September 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $92M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Steminent Biotherapeutics, and consider following 7729.TWO for alerts when major investors trade the stock.

Steminent Biotherapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $92M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 7729.TWO with unrelated industries.